STARTUP
Omini
Omini develops a new generation of Point of Care devices to enable portable decentralized blood testing where it is needed. Their core technology is built around electrochemical sensors that provide instantaneous, portable, and quantitative measuring of target biomarkers at an affordable price. Their goal is to build multi testing devices around this powerful technology, to provide fast biomarker testing and pave the way to predictive personalized medicine
Omini's Story
Clinical chemistry – such as blood tests – is essential for medical decisions but its turnaround time is not suitable for urgent decision making or monitoring of patients suffering from chronic diseases. It is also incompatible with the need for early detection, prevention, and monitoring.
Their goal is to bring blood testing into a new medical era. They want to develop a new generation of devices that is compatible with the growing need for decentralized medicine, in order to truly enable patient-centered care.